(a)Specifications. Each milliliter of sterile aqueous solution contains either 2 or 5 milligrams of yohimbine (as hydrochloride).
(b)Sponsor. See 061690 in § 510.600(c) of this chapter for use of 2 milligrams per milliliter solution in dogs.
(1)Amount. 0.05 milligram per pound (0.11 milligram per kilogram) of body weight.
(2)Indications for use. To reverse the effects of xylazine in dogs.
(3)Limitations. For intravenous use in dogs only. Not for use in food-producing animals. Safety of use in pregnant dogs or in dogs intended for breeding has not been established. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
(c)Sponsor. See 053923 in § 510.600(c) of this chapter for use of 5 milligrams per milliliter solution in deer and elk.
(1)Amount. 0.2 to 0.3 milligram per kilogram of body weight.
(2)Indications for use. As an antagonist to xylazine sedation in free ranging or confined members of the family Cervidae (deer and elk).
(3)Limitations. For intravenous use only. Do not use in domestic food-producing animals. Do not use for 30 days before or during hunting season. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[58 FR 8543, Feb. 16, 1993, as amended at 60 FR 57832, Nov. 22, 1995]
Title 21 published on 2014-04-01
The following are only the Rules published in the Federal Register after the published date of Title 21.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.